Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Sipkins DA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Whiteley AE; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Ma D; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Wang L; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Yu SY; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Yin C; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Price TT; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Simon BG; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Xu KR; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Marsh KA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Brockman ML; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Prioleau TM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Zhou KI; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA., Cui X; Department of Neurosurgery, Duke University, Durham, NC 27710, USA., Fecci PE; Department of Neurosurgery, Duke University, Durham, NC 27710, USA., Jeck WR; Department of Pathology, Duke University, Durham, NC 27710, USA., McCall CM; Department of Pathology, Duke University, Durham, NC 27710, USA., Neff JL; Department of Pathology, Duke University, Durham, NC 27710, USA., Sipkins DA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC 27710, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Jun 21; Vol. 384 (6702), pp. eadh5548. Date of Electronic Publication: 2024 Jun 21.
Autor:
Ridge SM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Whiteley AE; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Yao H; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Price TT; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Brockman ML; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Murray AS; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Simon BG; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Islam P; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Sipkins DA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Nov; Vol. 62 (11), pp. 2690-2702. Date of Electronic Publication: 2021 Aug 06.
Autor:
Whiteley AE; Department of Medicine, Duke University, Durham, NC, USA.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Price TT; Department of Medicine, Duke University, Durham, NC, USA., Cantelli G; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK., Sipkins DA; Department of Medicine, Duke University, Durham, NC, USA. dorothy.sipkins@duke.edu.; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. dorothy.sipkins@duke.edu.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2021 Jul; Vol. 21 (7), pp. 461-475. Date of Electronic Publication: 2021 May 05.
Autor:
Srinivasan ES; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Anders CK; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Pendergast AM; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Sipkins DA; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Ashley DM; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Fecci PE; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina., Khasraw M; Duke Brain and Spine Metastases Center, Duke University, Durham, North Carolina. mustafa.khasraw@duke.edu.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Mar; Vol. 20 (3), pp. 455-466. Date of Electronic Publication: 2021 Jan 05.